Safeguard Scientifics (SFES) 10-Q 12 Aug 22 2022 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2022	Aug. 08, 2022
Document Information [Line Items]
Entity Central Index Key	0000086115
Entity Registrant Name	SAFEGUARD SCIENTIFICS INC
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	1-5620
Entity Incorporation, State or Country Code	PA
Entity Tax Identification Number	23-1609753
Entity Address, Address Line One	150 N. Radnor Chester Road
Entity Address, City or Town	Radnor
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19087
City Area Code	610
Local Phone Number	293-0600
Title of 12(b) Security	common stock, par value $0.10
Trading Symbol	SFE
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Small Business	true
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		16,387,126

Consolidated Balance Sheets (Cu

Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 17,510	$ 24,739
Restricted cash	25	25
Ownership interests	2,407	4,549
Prepaid expenses and other current assets	1,126	965
Total current assets	21,068	30,278
Right-of-use asset, net	1,431	1,561
Ownership interests and advances	23,192	21,972
Other assets	267	217
Total Assets	45,958	54,028
Current Liabilities:
Accounts payable	56	41
Accrued compensation and benefits	167	794
Accrued expenses and other current liabilities	518	524
Lease liability - current	401	375
Total current liabilities	1,142	1,734
Lease liability - non-current	1,471	1,678
Other long-term liabilities	50	50
Total Liabilities	2,663	3,462
Commitments and contingencies (Note 9)
Equity:
Preferred stock, $0.10 par value; 1,000 shares authorized	0	0
Common stock, $0.10 par value; 83,333 shares authorized; 21,573 shares issued and outstanding at June 30, 2022 and December 31, 2021	2,157	2,157
Additional paid-in capital	805,441	806,638
Treasury stock, at cost; 5,261 and 5,068 shares at June 30, 2022 and December 31, 2021, respectively	(48,417)	(48,569)
Accumulated deficit	(715,861)	(709,635)
Accumulated other comprehensive loss	(25)	(25)
Total Equity	43,295	50,566
Total Liabilities and Equity	$ 45,958	$ 54,028

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares shares in Thousands	Jun. 30, 2022	Dec. 31, 2021
Preferred stock, par value (in dollars per share)	$ 0.10	$ 0.10
Preferred stock, shares authorized (in shares)	1,000	1,000
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common stock, shares authorized (in shares)	83,333	83,333
Common stock, shares issued (in shares)	21,573	21,573
Common stock, shares outstanding (in shares)	21,573	21,573
Treasury stock, shares (in shares)	5,261	5,068

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
General and administrative expense	$ 1,146	$ 1,991	$ 2,380	$ 4,454
Operating loss	(1,146)	(1,991)	(2,380)	(4,454)
Other income (loss), net	30	6,733	(1,967)	7,439
Interest income	145	74	246	127
Equity income (loss), net	1,454	(5,136)	(2,125)	14,193
Net income (loss) before income taxes	483	(320)	(6,226)	17,305
Income tax benefit (expense)	0	0	0	0
Net income (loss)	$ 483	$ (320)	$ (6,226)	$ 17,305
Net income (loss) per share:
Basic (in dollars per share)	$ 0.03	$ (0.02)	$ (0.38)	$ 0.83
Diluted (in dollars per share)	$ 0.03	$ (0.02)	$ (0.38)	$ 0.83
Weighted average shares used in computing income (loss) per share:
Basic (in shares)	16,356	20,856	16,468	20,879
Diluted (in shares)	16,356	20,856	16,468	20,879

Condensed Consolidated Statemen

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash Flows from Operating Activities:
Net cash used in operating activities	$ (2,099)	$ (4,734)
Cash Flows from Investing Activities:
Proceeds from sales of ownership interests	485	13,151
Advances and loans to ownership interests	(3,400)	(1,000)
Net cash (used in) provided by investing activities	(2,915)	12,151
Cash Flows from Financing Activities:
Repurchases of Company common stock	(1,723)	(1,588)
Tax withholdings related to equity-based awards	(492)	(100)
Net cash used in financing activities	(2,215)	(1,688)
Net change in cash, cash equivalents and restricted cash	(7,229)	5,729
Cash, cash equivalents and restricted cash at beginning of period	24,764	15,601
Cash, cash equivalents and restricted cash at end of period	$ 17,535	$ 21,330

Consolidated Statements of Chan

Consolidated Statements of Changes in Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Total
Balance at Dec. 31, 2020	$ (736,639)	$ (25)	$ 2,157	$ 807,582	$ (10,200)	$ 62,875
Balance (in shares) at Dec. 31, 2020			21,573		688
Net income (loss)	17,625	0	$ 0	0	$ 0	17,625
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net	0	0	$ 0	(593)	$ 963	370
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net (in shares)			0		(58)
Stock-based compensation expense	0	0	$ 0	122	$ 0	122
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net	0	0	0	593	(963)	(370)
Balance at Mar. 31, 2021	(719,014)	(25)	$ 2,157	807,111	$ (9,237)	80,992
Balance (in shares) at Mar. 31, 2021			21,573		630
Balance at Dec. 31, 2020	(736,639)	(25)	$ 2,157	807,582	$ (10,200)	62,875
Balance (in shares) at Dec. 31, 2020			21,573		688
Net income (loss)						17,305
Balance at Jun. 30, 2021	(719,334)	(25)	$ 2,157	806,447	$ (9,849)	79,396
Balance (in shares) at Jun. 30, 2021			21,573		786
Balance at Mar. 31, 2021	(719,014)	(25)	$ 2,157	807,111	$ (9,237)	80,992
Balance (in shares) at Mar. 31, 2021			21,573		630
Net income (loss)	(320)	0	$ 0	0	$ 0	(320)
Repurchases of common stock	0	0	$ 0	0	$ (1,588)	(1,588)
Repurchases of common stock (in shares)			0		229
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net	0	0	$ 0	839	$ (976)	(137)
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net (in shares)			0		(73)
Stock-based compensation expense	0	0	$ 0	175	$ 0	175
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net	0	0	0	(839)	976	137
Balance at Jun. 30, 2021	(719,334)	(25)	$ 2,157	806,447	$ (9,849)	79,396
Balance (in shares) at Jun. 30, 2021			21,573		786
Balance at Dec. 31, 2021	(709,635)	(25)	$ 2,157	806,638	$ (48,569)	50,566
Balance (in shares) at Dec. 31, 2021			21,573		5,068
Net income (loss)	(6,709)	0	$ 0	0	$ 0	(6,709)
Repurchases of common stock	0	0	$ 0	0	$ (779)	(779)
Repurchases of common stock (in shares)			0		148
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net	0	0	$ 0	(1,019)	$ 1,322	303
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net (in shares)			0		(122)
Stock-based compensation expense	0	0	$ 0	168	$ 0	168
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net	0	0	0	1,019	(1,322)	(303)
Balance at Mar. 31, 2022	(716,344)	(25)	$ 2,157	805,787	$ (48,026)	43,549
Balance (in shares) at Mar. 31, 2022			21,573		5,094
Balance at Dec. 31, 2021	(709,635)	(25)	$ 2,157	806,638	$ (48,569)	50,566
Balance (in shares) at Dec. 31, 2021			21,573		5,068
Net income (loss)						(6,226)
Balance at Jun. 30, 2022	(715,861)	(25)	$ 2,157	805,441	$ (48,417)	43,295
Balance (in shares) at Jun. 30, 2022			21,573		5,261
Balance at Mar. 31, 2022	(716,344)	(25)	$ 2,157	805,787	$ (48,026)	43,549
Balance (in shares) at Mar. 31, 2022			21,573		5,094
Net income (loss)	483	0	$ 0	0	$ 0	483
Repurchases of common stock	0	0	$ 0	0	$ (945)	(945)
Repurchases of common stock (in shares)			0		221
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net	0	0	$ 0	489	$ (554)	(65)
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net (in shares)			0		(54)
Stock-based compensation expense	0	0	$ 0	143	$ 0	143
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net	0	0	0	(489)	554	65
Balance at Jun. 30, 2022	$ (715,861)	$ (25)	$ 2,157	$ 805,441	$ (48,417)	$ 43,295
Balance (in shares) at Jun. 30, 2022			21,573		5,261

Note 1 - General

Note 1 - General	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. The accompanying unaudited interim Consolidated Financial Statements of Safeguard Scientifics, Inc. (“Safeguard” or the “Company”) were prepared in accordance with accounting principles generally accepted in the United States of America and the interim financial statement rules and regulations of the SEC. In the opinion of management, these statements include all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of the Consolidated Financial Statements. The interim operating results are not 10 10 2021 10 Liquidity As of June 30, 2022 In January 2018, may The Company believes that its cash and cash equivalents at June 30, 2022 one Principles of Accounting for Ownership Interests The Company accounts for its ownership interests using one In addition to holding voting and non-voting equity securities, the Company also periodically makes advances to its companies in the form of promissory notes which are included in the Ownership interests and advances on the Consolidated Balance Sheets. Equity Method. not not 20% 50% not third one When the Company’s carrying value in an equity method company is reduced to zero, the Company records no not not Other Method. not not not The Company accounts for ownership interests that are not June 30, 2022 Comprehensive Income (loss) During the quarter and six June 30, 2022 2021, no Impairment of Ownership Interests and Advances On a periodic basis, but no not Management then determines whether there has been an other than temporary decline in the value of its ownership interest in the company. Impairment is measured as the amount by which the carrying value of an asset exceeds its estimated fair value. The estimated fair value of privately held companies is generally determined based on the value at which independent third Impairment charges related to equity method companies are included in Equity income (loss), net in the Consolidated Statements of Operations. Impairment charges related to non-equity method companies are included in Other income (loss), net in the Consolidated Statements of Operations. The reduced cost basis of a previously impaired company accounted for using the Equity method is not

Note 2 - Ownership Interests an

Note 2 - Ownership Interests and Advances	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Investments in and Advances to Affiliates, Schedule of Investments [Text Block]	2. The following summarizes the carrying value of the Company’s ownership interests and advances. June 30, 2022 December 31, 2021 (Unaudited - In thousands) Equity Method: Companies $ 18,738 $ 21,091 Private equity funds 117 117 18,855 21,208 Other Method: Companies, fair value 2,407 4,549 Companies, fair value measurement alternative 687 514 Private equity funds, fair value measurement alternative 250 250 3,344 5,313 Advances to companies 3,400 — $ 25,599 $ 26,521 There were no three six June 30, 2022, three six June 30, 2021, As of June 30, 2022 9 June 30, 2022 Company Name Safeguard Primary Ownership as of June 30, 2022 Accounting Method Aktana, Inc. 13.4% Equity Clutch Holdings, Inc. 41.7% Equity InfoBionic, Inc. 25.2% Equity Lumesis, Inc. 43.2% Equity meQuilibrium 31.5% Equity Moxe Health Corporation 19.4% Equity Prognos Health Inc. 28.5% Equity Syapse, Inc. 11.0% Equity Trice Medical, Inc. 12.6% Equity Summarized Financial Information The following table summarizes the statement of operations data for the companies accounted for under the equity method for the three six June 30, 2022 2021 one not Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 (Unaudited - In thousands) Results of Operations: Revenue $ 36,479 $ 30,482 $ 75,290 $ 70,650 Gross profit $ 22,653 $ 17,873 $ 47,573 $ 46,101 Net loss $ (34,325 ) $ (28,681 ) $ (65,187 ) $ (51,702 )

Note 3 - Acquisitions of Owners

Note 3 - Acquisitions of Ownership Interests	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Equity Method and Other Investments Disclosure [Text Block]	3. The following is a summary of additional deployments during the six June 30, 2022 The Company funded $2.0 million of convertible loans to Prognos Health Inc. The Company had previously deployed an aggregate of $12.6 million. Prognos is a healthcare platform company transforming the ability to access, manage and analyze healthcare data in partnership with Life Sciences brands, payers, and clinical diagnostics organizations. Prognos' innovations enhance the value of laboratory results and clinical diagnostic data through advanced analytics and artificial intelligence techniques. The Company funded $1.4 million of convertible loans to Clutch Holdings, Inc. The Company had previously deployed an aggregate of $16.9 million. Clutch provides customer intelligence and personalized engagements that empower consumer-focused businesses to identify, understand and motivate each segment of their customer base.

Note 4 - Fair Value Measurement

Note 4 - Fair Value Measurements	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Fair Value Disclosures [Text Block]	4. The Company categorizes its financial instruments into a three 1 3 Cash, cash equivalents and restricted cash approximate fair value due to their short term nature. The Company did not 2 3 June 30, 2022 December 31, 2021. Carrying Fair Value Measurement at June 30, 2022 Value Level 1 Level 2 Level 3 (Unaudited - In thousands) Cash and cash equivalents $ 17,510 $ 17,510 $ — $ — Restricted cash $ 25 $ 25 $ — $ — Ownership interests $ 2,407 $ 2,407 $ — $ — Carrying Fair Value Measurement at December 31, 2021 Value Level 1 Level 2 Level 3 (Unaudited - In thousands) Cash and cash equivalents $ 24,739 $ 24,739 $ — $ — Restricted cash $ 25 $ 25 $ — $ — Ownership interests $ 4,549 $ 4,549 $ — $ — Ownership interests accounted for at fair value as of June 30, 2022

Note 5 - Stock-Based Compensati

Note 5 - Stock-Based Compensation	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	5. Stock-based compensation expense was recognized in the Consolidated Statements of Operations as follows: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 (Unaudited - In thousands) General and administrative expense $ 262 $ 740 $ 576 $ 985 $ 262 $ 740 $ 576 $ 985 Stock-based compensation consists of time based awards to employees, liability based awards to employees to be settled in stock, performance based awards to employees, other non-employee grants and liability based awards to Directors for quarterly and annual services. During the six June 30, 2022 2021 three June 30, 2022,

Note 6 - Income Taxes

Note 6 - Income Taxes	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	6. The Company recorded no three six June 30, 2022 2021 not three six June 30, 2022 three six June 30, 2022 no

Note 7 - Net Income (Loss) Per

Note 7 - Net Income (Loss) Per Share	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Earnings Per Share [Text Block]	7. The calculations of net income (loss) per share were as follows: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 (Unaudited - In thousands, except per share data) Basic: Net income (loss) $ 483 $ (320 ) $ (6,226 ) $ 17,305 Weighted average common shares outstanding 16,356 20,856 16,468 20,879 Net income (loss) per share $ 0.03 $ (0.02 ) $ (0.38 ) $ 0.83 Diluted: Net income (loss) for dilutive share computation $ 483 $ (320 ) $ (6,226 ) $ 17,305 Number of shares used in basic per share computation 16,356 20,856 16,468 20,879 Unvested restricted stock and DSU's — — — — Employee stock options — — — — Weighted average common shares outstanding 16,356 20,856 16,468 20,879 Net income (loss) per dilutive share $ 0.03 $ (0.02 ) $ (0.38 ) $ 0.83 Basic and diluted average common shares outstanding for purposes of computing net income (loss) per share includes outstanding common shares and vested deferred stock units (DSUs). If an equity method company has dilutive stock options, unvested restricted stock, DSUs or warrants, diluted net income (loss) per share is computed by first Diluted earnings per share do not • At June 30, 2022 2021 • At June 30, 2022 2021

Note 8 - Segment Reporting

Note 8 - Segment Reporting	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	8. The Company operates as one As of June 30, 2022 December 31, 2021

Note 9 - Commitments and Contin

Note 9 - Commitments and Contingencies	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	9. In March 2019, June 2019. April 2026, A summary of the Company's operating lease cash flows at June 30, 2022 Operating lease payments Expected sublease receipts (Unaudited - In thousands) 2022 (six months ending December 31) $ 302 $ 273 2023 607 557 2024 613 573 2025 619 590 2026 207 199 2027 — — Thereafter — — Total future minimum lease payments 2,348 $ 2,192 Less imputed interest (476 ) Total operating lease liabilities $ 1,872 The Company and the companies in which it holds ownership interests are involved in various claims and legal actions arising in the ordinary course of business. In the current opinion of the Company, it is not no one The Company has provided a guarantee, which is fully funded by escrowed funds held by a third June 30, 2022 one In 2018, February 2019 June 2020, January 2018. June 2020 first may 60 not six June 30, 2022 June 30, 2022 The Company has agreements with certain remaining employees that provide for severance payments to the employee in the event the employee is terminated without cause or an employee terminates his employment for “good reason.” The maximum aggregate exposure under employment and severance agreements for remaining employees was approximately $0.8 million at June 30, 2022 In June 2011, March 2012, July 2015 one 2014 one

Note 10 - Equity

Note 10 - Equity	6 Months Ended
	Jun. 30, 2022
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	10. In July 2015, not 2021 six June 30, 2022 In March 2022, May 2021 10b5 1 10b 18 1934, six June 30, 2022

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Liquidity, Policy [Policy Text Block]	Liquidity As of June 30, 2022 In January 2018, may The Company believes that its cash and cash equivalents at June 30, 2022 one
Investment, Policy [Policy Text Block]	Principles of Accounting for Ownership Interests The Company accounts for its ownership interests using one In addition to holding voting and non-voting equity securities, the Company also periodically makes advances to its companies in the form of promissory notes which are included in the Ownership interests and advances on the Consolidated Balance Sheets. Equity Method. not not 20% 50% not third one When the Company’s carrying value in an equity method company is reduced to zero, the Company records no not not Other Method. not not not The Company accounts for ownership interests that are not June 30, 2022
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Income (loss) During the quarter and six June 30, 2022 2021, no
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Ownership Interests and Advances On a periodic basis, but no not Management then determines whether there has been an other than temporary decline in the value of its ownership interest in the company. Impairment is measured as the amount by which the carrying value of an asset exceeds its estimated fair value. The estimated fair value of privately held companies is generally determined based on the value at which independent third Impairment charges related to equity method companies are included in Equity income (loss), net in the Consolidated Statements of Operations. Impairment charges related to non-equity method companies are included in Other income (loss), net in the Consolidated Statements of Operations. The reduced cost basis of a previously impaired company accounted for using the Equity method is not

Note 2 - Ownership Interests _2

Note 2 - Ownership Interests and Advances (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block]	June 30, 2022 December 31, 2021 (Unaudited - In thousands) Equity Method: Companies $ 18,738 $ 21,091 Private equity funds 117 117 18,855 21,208 Other Method: Companies, fair value 2,407 4,549 Companies, fair value measurement alternative 687 514 Private equity funds, fair value measurement alternative 250 250 3,344 5,313 Advances to companies 3,400 — $ 25,599 $ 26,521
Schedule of Other Ownership Interests [Table Text Block]	Company Name Safeguard Primary Ownership as of June 30, 2022 Accounting Method Aktana, Inc. 13.4% Equity Clutch Holdings, Inc. 41.7% Equity InfoBionic, Inc. 25.2% Equity Lumesis, Inc. 43.2% Equity meQuilibrium 31.5% Equity Moxe Health Corporation 19.4% Equity Prognos Health Inc. 28.5% Equity Syapse, Inc. 11.0% Equity Trice Medical, Inc. 12.6% Equity
Equity Method Investments [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 (Unaudited - In thousands) Results of Operations: Revenue $ 36,479 $ 30,482 $ 75,290 $ 70,650 Gross profit $ 22,653 $ 17,873 $ 47,573 $ 46,101 Net loss $ (34,325 ) $ (28,681 ) $ (65,187 ) $ (51,702 )

Note 4 - Fair Value Measureme_2

Note 4 - Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Carrying Fair Value Measurement at June 30, 2022 Value Level 1 Level 2 Level 3 (Unaudited - In thousands) Cash and cash equivalents $ 17,510 $ 17,510 $ — $ — Restricted cash $ 25 $ 25 $ — $ — Ownership interests $ 2,407 $ 2,407 $ — $ — Carrying Fair Value Measurement at December 31, 2021 Value Level 1 Level 2 Level 3 (Unaudited - In thousands) Cash and cash equivalents $ 24,739 $ 24,739 $ — $ — Restricted cash $ 25 $ 25 $ — $ — Ownership interests $ 4,549 $ 4,549 $ — $ —

Note 5 - Stock-Based Compensa_2

Note 5 - Stock-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Share-Based Payment Arrangement, Activity [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 (Unaudited - In thousands) General and administrative expense $ 262 $ 740 $ 576 $ 985 $ 262 $ 740 $ 576 $ 985

Note 7 - Net Income (Loss) Pe_2

Note 7 - Net Income (Loss) Per Share (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 (Unaudited - In thousands, except per share data) Basic: Net income (loss) $ 483 $ (320 ) $ (6,226 ) $ 17,305 Weighted average common shares outstanding 16,356 20,856 16,468 20,879 Net income (loss) per share $ 0.03 $ (0.02 ) $ (0.38 ) $ 0.83 Diluted: Net income (loss) for dilutive share computation $ 483 $ (320 ) $ (6,226 ) $ 17,305 Number of shares used in basic per share computation 16,356 20,856 16,468 20,879 Unvested restricted stock and DSU's — — — — Employee stock options — — — — Weighted average common shares outstanding 16,356 20,856 16,468 20,879 Net income (loss) per dilutive share $ 0.03 $ (0.02 ) $ (0.38 ) $ 0.83

Note 9 - Commitments and Cont_2

Note 9 - Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2022
Notes Tables
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	Operating lease payments Expected sublease receipts (Unaudited - In thousands) 2022 (six months ending December 31) $ 302 $ 273 2023 607 557 2024 613 573 2025 619 590 2026 207 199 2027 — — Thereafter — — Total future minimum lease payments 2,348 $ 2,192 Less imputed interest (476 ) Total operating lease liabilities $ 1,872

Note 1 - General (Details Textu

Note 1 - General (Details Textual) - USD ($) $ in Thousands, shares in Millions	Jun. 30, 2022	Dec. 31, 2021
Cash and Cash Equivalents, at Carrying Value, Total	$ 17,510	$ 24,739
Debt Securities, Trading, and Equity Securities, FV-NI, Total	$ 2,407	$ 4,549
Bright Health [Member]
Investment Owned, Balance, Shares (in shares)	1.3
Debt Securities, Trading, and Equity Securities, FV-NI, Total	$ 2,400

Note 2 - Ownership Interests _3

Note 2 - Ownership Interests and Advances (Details Textual) $ in Millions	6 Months Ended
	Jun. 30, 2022 USD ($)
Impairment of Other Method Securities	$ 2.5

Note 2 - Ownership Interests _4

Note 2 - Ownership Interests and Advances - Schedule of Carrying Value of Ownership Interests (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Equity Method Companies	$ 18,855	$ 21,208
Ownership interests	2,407	4,549
Other Method, fair value measurement alternative	3,344	5,313
Advances to companies	3,400	0
Investments and Advances to Affiliates, Current and Noncurrent	25,599	26,521
Partnership Interest [Member]
Equity Method Companies	18,738	21,091
Ownership interests	2,407	4,549
Other Method, fair value measurement alternative	687	514
Private Equity Funds [Member]
Equity Method Companies	117	117
Other Method, fair value measurement alternative	$ 250	$ 250

Note 2 - Ownership Interests _5

Note 2 - Ownership Interests and Advances - Schedule of Ownership Interests (Details)	Jun. 30, 2022
Aktana, Inc. [Member]
Ownership Interest	13.40%
Clutch Holdings [Member]
Ownership Interest	41.70%
InfoBionic, Inc. [Member]
Ownership Interest	25.20%
Lumesis, Inc. [Member]
Ownership Interest	43.20%
meQuilibrium [Member]
Ownership Interest	31.50%
Moxe Health Corporation [Member]
Ownership Interest	19.40%
Prognos Health, Inc. [Member]
Ownership Interest	28.50%
Syapse, Inc. [Member]
Ownership Interest	11%
Trice Medical, Inc. [Member]
Ownership Interest	12.60%

Note 2 - Ownership Interests _6

Note 2 - Ownership Interests and Advances - Schedule of Results of Operations (Details) - Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member] - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenue	$ 36,479	$ 30,482	$ 75,290	$ 70,650
Gross profit	22,653	17,873	47,573	46,101
Net loss	$ (34,325)	$ (28,681)	$ (65,187)	$ (51,702)

Note 3 - Acquisitions of Owne_2

Note 3 - Acquisitions of Ownership Interests (Details Textual) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Equity Method Investments	$ 18,855	$ 21,208
Prognos Health, Inc. [Member]
Convertible Bridge Loan	2,000
Equity Method Investments	12,600
Clutch Holdings [Member]
Convertible Bridge Loan	1,400
Equity Method Investments	$ 16,900

Note 4 - Fair Value Measureme_3

Note 4 - Fair Value Measurements (Details Textual) shares in Millions	Jun. 30, 2022 shares
Bright Health [Member]
Investment Owned, Balance, Shares (in shares)	1.3

Note 4 - Fair Value Measureme_4

Note 4 - Fair Value Measurements - Fair Value of Assets and Liabilities Measured On Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Reported Value Measurement [Member]
Cash and cash equivalents	$ 17,510	$ 24,739
Restricted cash	25	25
Ownership interests	2,407	4,549
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]
Cash and cash equivalents	17,510	24,739
Restricted cash	25	25
Ownership interests	2,407	4,549
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 2 [Member]
Cash and cash equivalents	0	0
Restricted cash	0	0
Ownership interests	0	0
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]
Cash and cash equivalents	0	0
Restricted cash	0	0
Ownership interests	$ 0	$ 0

Note 5 - Stock-Based Compensa_3

Note 5 - Stock-Based Compensation (Details Textual) - shares shares in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2021
Share-Based Payment Arrangement, Nonemployee [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period (in shares)	15
Share-Based Payment Arrangement, Employee [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period (in shares)	162
Restricted Stock [Member] | Share-Based Payment Arrangement, Nonemployee [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period (in shares)		25	64

Note 5 - Stock-based Compensa_4

Note 5 - Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
General and administrative expense	$ 262	$ 740	$ 576	$ 985
General and Administrative Expense [Member]
General and administrative expense	$ 262	$ 740	$ 576	$ 985

Note 7 - Net Income (Loss) Pe_3

Note 7 - Net Income (Loss) Per Share (Details Textual) - $ / shares shares in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	18	43
Share-Based Payment Arrangement, Option [Member] | Minimum [Member]
Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit (in dollars per share)	$ 10.37	$ 10.37
Share-Based Payment Arrangement, Option [Member] | Maximum [Member]
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit (in dollars per share)	$ 17.11	$ 17.11
Restricted Stock, Performance-based Stock Units, and Deferred Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	100	300

Note 7 - Net Income (Loss) Pe_4

Note 7 - Net Income (Loss) Per Share - Calculations of Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021
Basic:
Net income (loss)	$ 483	$ (6,709)	$ (320)	$ 17,625	$ (6,226)	$ 17,305
Basic (in shares)	16,356		20,856		16,468	20,879
Basic (in dollars per share)	$ 0.03		$ (0.02)		$ (0.38)	$ 0.83
Diluted:
Net income (loss)	$ 483	$ (6,709)	$ (320)	$ 17,625	$ (6,226)	$ 17,305
Basic (in shares)	16,356		20,856		16,468	20,879
Unvested restricted stock and DSU's (in shares)	0		0		0	0
Employee stock options (in shares)	0		0		0	0
Diluted (in shares)	16,356		20,856		16,468	20,879
Diluted (in dollars per share)	$ 0.03		$ (0.02)		$ (0.38)	$ 0.83

Note 8 - Segment Reporting (Det

Note 8 - Segment Reporting (Details Textual)	6 Months Ended
	Jun. 30, 2022
Number of Operating Segments	1

Note 9 - Commitments and Cont_3

Note 9 - Commitments and Contingencies (Details Textual) $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($)
Long-term Incentive Plan, Payments	$ 0
Deferred Compensation Liability, Current and Noncurrent, Total	0
Employee and Severance Agreement, Maximum Aggregate Exposure	$ 800
Minimum [Member]
Long-term Incentive Plan, Bonus Pool Percent	1%
Maximum [Member]
Long-term Incentive Plan, Bonus Pool Percent	1.30%
Private Equity Funds [Member]
Guarantor Obligations, Current Carrying Value	$ 3,800

Note 9 - Commitments and Cont_4

Note 9 - Commitments and Contingencies - Operating Lease Cash Flow (Details) $ in Thousands	Jun. 30, 2022 USD ($)
2022 (six months ending December 31)	$ 302
2022 (six months ending December 31)	273
2023, Operating lease payments	607
2023, Expected sublease receipts	557
2024, Operating lease payments	613
2024, Expected sublease receipts	573
2025, Operating lease payments	619
2025, Expected sublease receipts	590
2026, Operating lease payments	207
2026, Expected sublease receipts	199
2027, Operating lease payments	0
2027, Expected sublease receipts	0
Thereafter, Operating lease payments	0
Thereafter, Expected sublease receipt	0
Total future minimum lease payments, Operating lease payments	2,348
Total future minimum lease payments, Expected sublease receipt	2,192
Less imputed interest, Operating lease payments	(476)
Total operating lease liabilities, Operating lease payments	$ 1,872

Note 10 - Equity (Details Textu

Note 10 - Equity (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Jul. 31, 2015
Treasury Stock, Value, Acquired, Cost Method	$ 945	$ 779	$ 1,588
Share Repurchase Program Authorized in July 2015 [Member]
Stock Repurchase Program, Authorized Amount						$ 25,000
Treasury Stock, Shares, Acquired (in shares)				0	0
Share Repurchase Program Authorized in May 2021 [Member]
Stock Repurchase Program, Authorized Amount		$ 3,000
Treasury Stock, Shares, Acquired (in shares)				369,274
Treasury Stock, Value, Acquired, Cost Method				$ 1,700
Treasury Stock Acquired, Average Cost Per Share (in dollars per share)				$ 4.67